X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (4019) 4019
Book Review (1718) 1718
Publication (388) 388
Book Chapter (98) 98
Book / eBook (7) 7
Conference Proceeding (6) 6
Government Document (6) 6
Magazine Article (3) 3
Newspaper Article (3) 3
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (3350) 3350
humans (3070) 3070
oncology (2021) 2021
female (1817) 1817
cancer (1619) 1619
chemotherapy (1110) 1110
middle aged (1082) 1082
aged (939) 939
adult (863) 863
animals (799) 799
male (739) 739
care and treatment (659) 659
ovarian cancer (576) 576
pharmacology & pharmacy (561) 561
treatment outcome (542) 542
advanced solid tumors (534) 534
research (527) 527
health aspects (518) 518
prognosis (511) 511
antineoplastic agents - therapeutic use (493) 493
neoplasms - drug therapy (475) 475
advanced basic science (472) 472
neoplasm staging (472) 472
survival (470) 470
obstetrics & gynecology (465) 465
antineoplastic combined chemotherapy protocols - therapeutic use (464) 464
medicine & public health (461) 461
analysis (454) 454
carcinoma (449) 449
cell lung-cancer (414) 414
tumors (413) 413
surgery (403) 403
aged, 80 and over (373) 373
hematology, oncology and palliative medicine (360) 360
metastasis (355) 355
ovarian neoplasms - pathology (339) 339
cisplatin (316) 316
ovarian neoplasms - drug therapy (313) 313
retrospective studies (296) 296
advanced breast-cancer (284) 284
phase-ii trial (284) 284
breast-cancer (280) 280
breast cancer (278) 278
clinical trials (276) 276
clinical trials as topic (273) 273
cell biology (267) 267
article (266) 266
neoadjuvant chemotherapy (264) 264
antineoplastic agents - pharmacology (246) 246
disease-free survival (246) 246
drug therapy (245) 245
paclitaxel (244) 244
review (241) 241
therapy (234) 234
survival rate (232) 232
immunotherapy (230) 230
ovarian neoplasms - surgery (230) 230
cancer therapies (228) 228
antineoplastic agents (225) 225
hematology (217) 217
mice (217) 217
development and progression (216) 216
phase-iii trial (215) 215
antimitotic agents (214) 214
advanced ovarian cancer (211) 211
medicine, research & experimental (211) 211
advanced ovarian-cancer (209) 209
cell line, tumor (205) 205
apoptosis (203) 203
survival analysis (203) 203
oncology, experimental (201) 201
biochemistry & molecular biology (200) 200
patients (196) 196
phase-i (196) 196
cancer research (194) 194
gynecologic-oncology-group (190) 190
antineoplastic agents - administration & dosage (188) 188
combined modality therapy (188) 188
obstetrics and gynecology (188) 188
medical research (186) 186
quality of life (185) 185
antineoplastic agents - adverse effects (182) 182
antineoplastic combined chemotherapy protocols - adverse effects (182) 182
breast neoplasms - drug therapy (182) 182
genetic aspects (181) 181
expression (179) 179
radiotherapy (178) 178
advanced cancer (175) 175
cancer patients (175) 175
ovarian-cancer (175) 175
angiogenesis (174) 174
neoplasms - pathology (174) 174
trial (174) 174
risk factors (173) 173
neoplasms - therapy (170) 170
endothelial growth-factor (167) 167
paclitaxel - administration & dosage (167) 167
neoplasms - metabolism (166) 166
phase-ii (164) 164
dentistry (162) 162
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (4078) 4078
French (30) 30
German (8) 8
Japanese (3) 3
Polish (3) 3
Spanish (3) 3
Romanian (2) 2
Italian (1) 1
Korean (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Gynecologic Oncology, ISSN 0090-8258, 2016, Volume 140, Issue 3, pp. 436 - 442
Journal Article
Yonsei medical journal, ISSN 0513-5796, 10/2018, Volume 59, Issue 8, pp. 930 - 936
Purpose: Outcomes in patients with ovarian high-grade serous carcinoma (HGSC) treated with neoadjuvant chemotherapy (NAC) have been widely studied; however,... 
adenocarcinoma, clear cell | survival rate | adenocarcinoma, mucinous | neoadjuvant therapy | Ovarian neoplasm | MORTALITY | SURVIVAL | ADVANCED EPITHELIAL OVARIAN | 1ST-LINE CHEMOTHERAPY | clear cell | adenocarcinoma | mucinous | HISTOLOGY | FEATURES | TRIAL | MEDICINE, GENERAL & INTERNAL | PRIMARY SURGERY | THERAPY | PACLITAXEL PLUS CARBOPLATIN | Index Medicus | Original
Journal Article
Gynecologic Oncology, ISSN 0090-8258, 2013, Volume 131, Issue 2, pp. 357 - 361
Journal Article
Gynecologic Oncology, ISSN 0090-8258, 2012, Volume 125, Issue 2, pp. 362 - 366
Journal Article
Gynecologic Oncology, ISSN 0090-8258, 2011, Volume 124, Issue 3, pp. 575 - 581
Abstract Purpose Efflux transporters of the ATP-binding cassette (ABC) family are major determinants of chemoresistance in tumor cells. This study examined... 
Hematology, Oncology and Palliative Medicine | Obstetrics and Gynecology | ABCB1 | ABCC2 | Common variants | GOG | Advanced stage ovarian cancer | MULTIDRUG TRANSPORTER | RESISTANCE PROTEIN | PACLITAXEL RESISTANCE | DRUG-RESISTANCE | P-GLYCOPROTEIN | OBSTETRICS & GYNECOLOGY | CELL LUNG-CANCER | ONCOLOGY | MDR1 GENE | EXPRESSION | MRP2 ABCC2 | SINGLE NUCLEOTIDE POLYMORPHISMS | ATP Binding Cassette Transporter, Sub-Family G, Member 2 | Deoxycytidine - administration & dosage | Humans | Middle Aged | Carboplatin - administration & dosage | Cisplatin - administration & dosage | Polymorphism, Genetic | Ovarian Neoplasms - genetics | Young Adult | ATP-Binding Cassette Transporters - genetics | ATP-Binding Cassette, Sub-Family B, Member 1 - genetics | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Aged, 80 and over | Topotecan - administration & dosage | Adult | Female | Multidrug Resistance-Associated Proteins - genetics | ATP Binding Cassette Transporter, Sub-Family B | Aged | Neoplasm Proteins - genetics | Paclitaxel - administration & dosage | Ovarian Neoplasms - drug therapy | Deoxycytidine - analogs & derivatives | Doxorubicin - administration & dosage | Women | Medical colleges | Chemotherapy | Patient outcomes | Genes | Oncology, Experimental | Genetic research | Genetic aspects | Research | Ovarian cancer | Cancer | Index Medicus
Journal Article
Value in Health : The Journal of the International Society for Pharmacoeconomics and Outcomes Research, ISSN 1098-3015, 05/2017, Volume 20, Issue 5, p. A240
OBJECTIVES: To develop an economic impact of BRCA1 and BRCA2 genetic tests in women with advanced stage ovarian cancer in the Colombian context. METHODS: Using... 
Savings | Experts | Genes | Scientific evidence | Medical diagnosis | Impact analysis | Ovarian cancer | Databases | Genetic analysis | Clinical guidelines | Advanced stage | Public health | Women | BRCA2 protein | Statistical analysis | At risk | Sensitivity analysis | BRCA1 protein | Breast cancer | Patients | Clinical practice | Sensitivity | Health care expenditures | Relatives | Genetic testing
Journal Article
Radiology and Oncology, ISSN 1318-2099, 09/2018, Volume 52, Issue 3, pp. 307 - 319
Background. The aim of the study was to analyze the overall survival (OS) and progression free survival (PFS) of patients with high grade and advanced stage... 
neoadjuvant chemotherapy | adjuvant chemotherapy | advanced stage | primary debulking surgery | overall survival | epithelial ovarian cancer | progression free survival | interval debulking surgery | COMPLETE CYTOREDUCTION | MANAGEMENT | MEMBERS | SOCIETY | CARE | WOMEN | ONCOLOGY | QUALITY-OF-LIFE | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | EPITHELIAL OVARIAN
Journal Article